HUMAN AMYLOID PRECURSOR-LIKE PROTEIN-1 - CDNA CLONING, ECTOPIC EXPRESSION IN COS-7 CELLS AND IDENTIFICATION OF SOLUBLE FORMS IN THE CEREBROSPINAL-FLUID
K. Paliga et al., HUMAN AMYLOID PRECURSOR-LIKE PROTEIN-1 - CDNA CLONING, ECTOPIC EXPRESSION IN COS-7 CELLS AND IDENTIFICATION OF SOLUBLE FORMS IN THE CEREBROSPINAL-FLUID, European journal of biochemistry, 250(2), 1997, pp. 354-363
Amyloid precursor-like protein 1 (APLP1) represents an integral membra
ne type 1 protein of unknown function which was originally cloned from
a mouse cDNA library on the basis of sequence similarity with the Alz
heimer's amyloid precursor protein (APP). Here we report on the molecu
lar cloning and expression of the human APLP1 (hAPLP1). hAPLP1 consist
s of 650 amino acids, displays 89% identity on the amino acid level to
its mouse homologue and has a calculated molecular mass of 72 kDa, hA
PLP1 synthesized in a cell-free system displays an apparent molecular
mass of approximate to 80 kDa in SDS-containing gels and becomes N-gly
cosylated when the in vitro translation is performed in the presence o
f microsomes. The hAPLP1 cDNA was also expressed ectopically in COS-7
cells and the protein expression was analyzed by immunoprecipitation a
nd western blotting. We have demonstrated that hAPLP1 represents a nov
el glycoprotein which carries both N- and O-linked glycans. Moreover,
hAPLP1 undergoes limited proteolysis which results in the secretion of
the carboxy-terminal truncated molecule into the cells conditioned me
dium. Examination of cells transfected with hAPLP1 cDNA by confocal la
ser microscopy reveals an intense perinuclear and Golgi staining, a pa
ttern resembling the subcellular distribution of APP. Using a novel hA
PLP1-specific antiserum, we identified soluble hAPLP1 in the human cer
ebrospinal fluid, which suggests that secretion of hAPLP1 from brain c
ells also takes place in vivo.